LAB. CORP.OF AMER. DL-,10
LAB. CORP.OF AMER. DL-,10/ US50540R4092 /
LAB
|
14/05/2024 11:16:03
|
Diferencia
+2.00
|
Volumen |
Bid11:16:03 |
Ask11:16:03 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
195.00EUR
|
+1.04%
|
-
Volumen de negocios: - |
195.00Volumen de oferta: - |
197.00Tamaño/ Volumen/ Formato de Ask: - |
16.43 mil millonesEUR |
- |
- |
Descripción de negocio
Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
Consejo de gestión & Consejo de supervisión
| CEO |
| Adam Schechter |
| Consejo de gestión |
| Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson |
| Consejo de supervisión |
| Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D. |
Datos de la empresa
| Nombre: |
Laboratory Corporation of America Holdings |
| Dirección: |
531 South Spring Street,Burlington, North Carolina 27215, USA |
| Teléfono: |
+1-336-229-1127 |
| Fax: |
+1-336-436-1569 |
| E-mail: |
-
|
| Internet: |
https://www.labcorp.com/ |
| Industria: |
Healthcare |
| Sector: |
Medical Products |
| Subsector: |
Advanced Medical Devices |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
78.40% |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Chas Cook |
| IR teléfono: |
+1-336-436-5076 |
| IR-fax: |
336-436-1569 |
| IR e-mail: |
investor@labcorp.com
|
